DEFERITAZOLE
UNII 4D8DC53Y1L

Substance Identification & Data

This profile provides standardized clinical and technical data for Deferitazole, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 4D8DC53Y1L.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 945635-15-4 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

4D8DC53Y1L

CAS Registry Number

945635-15-4

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

DEFERITAZOLE

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C18H25NO7S

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

AWHIMFSHNAAMBM-GOSISDBHSA-N

Line notation for describing the chemical structure and connectivity of atoms.

NCI Thesaurus

C166753

National Cancer Institute reference terminology for clinical and research data.

PubChem CID

135565672

Unique identification number in the NCBI database of chemical substances.

INN ID

9659

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

YY-59

Identifier assigned by the United States Adopted Names Council.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

OC(=O)[C@@]1(C)CSC(=N1)c2cccc(OCCOCCOCCOC)c2O

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Deferitazole. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.